National and Kapodistrian University of Athens
Ο ρόλος πεπτιδίων στην εκτίμηση της βαρύτητας και της εξέλιξης συγγενών καρδιοπαθειών στα παιδιά
Abstract
dc:descriptionIntroduction: The course and outcome of congenital heart disease is highly dependent on early diagnosis and accurate assessment of severity. Vasoactive peptides may be useful in the initial evaluation of congenital heart disease, in the follow-up assessment and in the evaluation of the effectiveness of treatment. Purpose: To compare brain natriuretic peptide (BNP), adrenomedullin (ADM) and urotensin II (UII) plasma levels in patients presenting with non-cyanotic heart disease, and to examine their potential relationship with the presence, the severity and the type of the disease. Material-Methods: 78 subjects [median age 11.56 (1.58-83.75) months], 39 with congenital heart disease - atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA)- and 39 age- and gender matched controls, were enrolled. Study protocol included family, prenatal and medical history, clinical evaluation, routine laboratory work-up and cardiac ultrasound. Plasma BNP, ADM and UII levels were measured using ELISA. Statistical analyses were performed using SPSS v20 and p<0.005 was considered as significant. Results: Patients had significantly higher BNP levels (p=0,006), marginally higher ADM levels (p=0,063) and similar UII levels (p=0,635) compared to controls. BNP levels were lower among PDA patients compared to VSD and ASD patients. ADM and UII levels were marginally higher in patients with moderate and severe heart disease than those with mild disease. BNP levels were not related to disease severity. Moreover, higher incidence of failure to thrive and underweight was observed in patients compared to healthy controls. Finally, maternal smoking was more prevalent among patients. Conclusion: The vasoactive peptides’ plasma levels are differentially associated with the presence and the severity of non-cyanotic heart disease. BNP and, to a lesser extent, ADM levels may be useful as diagnostic markers for the presence of congenital heart disease. ADM and UII levels may reflect disease severity. BNP is more useful for the diagnosis of ASD.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papachristou, Panagiota
- Παπαχρήστου, Παναγιώτα
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41186